$1.620
+0.383 (+23.66%)終値時点
- 高値
- 1.670
- 始値
- 1.370
- 出来高加重平均価格
- 1.55
- 出来高
- 395.55K
- 時価総額
- —
- 安値
- 1.361
- 売買代金
- 613.19K
- EV/EBITDA（TTM）
- 0.00
AI分析 of Davion Healthcare Plc Ordinary Shares (DAVI)
売りDaviion Healthcare Plc is not a good buy right now due to its significant decline in value and lack of positive financial indicators. The stock has dropped 89.17% year-to-date and is currently trading at $1.49, which is very close to its 52-week low of $1.46. Additionally, the company has a price-to-book ratio of 31.6019, indicating it is highly overvalued compared to its assets. The recent acquisitions may provide some future potential, but the current performance and high risk outweigh these factors.
バリュエーション指標
ニュース
DAVI のよくある質問 — Alphio AI が回答
Daviion Healthcare Plc is not a good buy right now due to its significant decline in value and lack of positive financial indicators. The stock has dropped 89.17% year-to-date and is currently trading at $1.49, which is very close to its 52-week low of $1.46. Additionally, the company has a price-to-book ratio of 31.6019, indicating it is highly overvalued compared to its assets. The recent acquisitions may provide some future potential, but the current performance and high risk outweigh these factors.
コミュニティ
もっと見る ↗投稿はまだありません
登録またはログインして議論に参加関連記事
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。